Myovant Sciences
+$0.11 (+0.54%) As of 3:49 PM UTC today
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MYOV and other ETFs, options, and stocks.
About MYOV
Myovant Sciences, Inc. is a clinical-stage biopharmaceutical company. The firm focuses on the development and commercialization of therapies for the treatment of women's health and endocrine diseases.
CEO
David C. Marek
Employees
407
Headquarters
London, Greater London
Founded
2016
MYOV Key Statistics
Market Cap
1.87B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
361.30K
High Today
$20.43
Low Today
$20.11
Open Price
$20.20
Volume
89.72K
52 Week High
$30.90
52 Week Low
$13.59
Analyst Ratings
67%
of 6 ratings
Buy
66.7%
Hold
33.3%
Sell
0%
MYOV Earnings
-$0.99
-$0.66
-$0.33
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Available Oct 26, Pre-Market